title: Meningococcal meningitis epidemic. A new role for single-dose oily chloramphenicol.
abstract: OBJECTIVE
  To compare the orthodox use of 5 days crystalline penicillin and an alternate regime of single intramuscular injection of long acting oily chloramphenicol during the 1999 cerebrospinal meningitis epidemic that occurred in Abu Jubeha, South Kordofan, Sudan.
  
  
  METHODS
  All 793 patients with meningococcal meningitis admitted to Abu Jubeha hospital in the eastern parts of South Kordofan State, were investigated. Through a quasi-experimental design some 140 patients were treated with crystalline penicillin for 5 days while the remaining majority, after the exhaustion of penicillin stocks, were put on single-dose intramuscular injections of oily long-acting chloramphenicol.
  
  
  RESULTS
  Males were slightly more affected than females (1.3:1), mean age affected was 17.2 years, the majority being below 20 years of age (68%) while 27.3% were below 10 years. The peak of the epidemic was during late March and early April namely 9th and 10th epidemic weeks. In the penicillin group 87.1% recovered uneventfully, 6.4% died, 2.1% developed blindness and 1.5% partial deafness. In the chloramphenicol group, full recovery was reported in 92.8%, 5% fatalities, blindness in 0.5%, partial deafness in 0.3% and skin necrosis in 0.1%.
  
  
  CONCLUSIONS
  The study suggests the use of single-dose intramuscular injections of oily chloramphenicol as a nationwide antibiotic of choice for future meningitis epidemics in view of not only its efficacy, but also its low cost, easiness of use, stability and safety.
authors.affiliation: Department of Community Medicine and Public Health, Faculty of Medicine and Health Sciences, International University of Africa.
authors.forename: Asim A
authors.initials: AA
authors.lastname: Hussein
authors.forename: Salah I
authors.initials: SI
authors.lastname: Abdel Rahman
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002701:Chloramphenicol / Q000008:administration & dosage / Q000627:therapeutic use*; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D008297:Male; D008585:Meningitis, Meningococcal / Q000188:drug therapy* / Q000453:epidemiology*; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D013397:Sudan / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D010406:Penicillins; D002701:Chloramphenicol